Drug Pricing

Commentary

Learning The Right Lessons From The Race For An Effective Covid-19 Treatment

On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
Commentary

Price controls punish U.S. innovators and economy

America’s biopharmaceutical industry dwarfs most other economic sectors. It’s one of our nation’s single biggest job creators, supporting close to a million positions across the country. And its products save countless lives each year. Yet for some reason, politicians in both parties seem determined to snuff it out by imposing ...
Blog

What We’re Watching – June 19

Tim Anaya – How Medicines in the U.S. are Sold In the latest video in PRI’s “Escape the Drug Pricing Maze” video, the Professor and Pete reach the most difficult part of their journey: understanding how medicines are sold. It’s a complex system that hurts patients and at times exposes ...
Blog

What We’re Watching – June 5

Tim Anaya – Digging Up Ways to Lower Costs for High Value but Expensive Drugs In the latest video in the “Escape the Drug Pricing Maze” video, Sage the Detective Dog digs up clues on biologics and gene therapies – drugs that offer tremendous value for patients but are some ...
Agriculture

What We’re Watching – May 22

Rowena Itchon – A Memorial Day Tribute 2020 Kerry Jackson – This Doctor Won’t Take Health Insurance – and Charges Just $35 a Visit Meet the Pittsburgh doctor who doesn’t take health care insurance and charges only $35 for most office visits. That makes him a doctor from a different era. But ...
Blog

What We’re Watching – May 8

Rowena Itchon – Love in the Time of Coronavirus Watch some of our front line medical personnel battling COVID-19 and helping people stay alive take a much-needed break to recreate the iconic scene from Titanic, with an usual, personal protective equipment-themed twist. Kerry Jackson – Dorothy’s Song, COVID-19 Version Somewhere, ...
Coronavirus

Sally Pipes – The Push for Government-Run Health Care During the Coronavirus Crisis

PRI President, CEO, and Thomas W. Smith Fellow in Health Care Studies Sally C. Pipes is back to discuss some of the health care challenges that have popped up during the coronavirus crisis, including a renewed push for single-payer and calls for prescription drug price controls and a “Buy America” ...
Blog

What We’re Watching – April 24

Tim Anaya – Taking a Time Machine to a Lower Drug Price Future In the latest video in the “Escape the Drug Pricing Maze” series, Professor Salvare takes Pete Paystoomuch in a time machine to learn how drugs become cheaper after higher initial costs that incentivize innovation. Then they go ...
Blog

COVID-19 Reminds Us That Both Innovation and Affordability Are Needed

In her March 25 Forbes editorial, Sally Pipes documented how the private sector is rising to the health challenges of the coronavirus. Whether it is Moderna launching clinical trials for a COVID-19 vaccine or Gilead Sciences investigating whether one of its medicines, Remdesivir, is effective against the coronavirus, private sector ...
Blog

What We’re Watching – Good Friday Edition

Tim Anaya – The Crossroads of Innovation and Affordability In the latest “Escape the Drug Pricing Maze” video, On the first step toward escaping the Drug Pricing Maze, Professor Salvare takes Pete Paystoomuch down the path of drug innovation, showing him why drug prices are initially more expensive – to ...
Commentary

Learning The Right Lessons From The Race For An Effective Covid-19 Treatment

On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
Commentary

Price controls punish U.S. innovators and economy

America’s biopharmaceutical industry dwarfs most other economic sectors. It’s one of our nation’s single biggest job creators, supporting close to a million positions across the country. And its products save countless lives each year. Yet for some reason, politicians in both parties seem determined to snuff it out by imposing ...
Blog

What We’re Watching – June 19

Tim Anaya – How Medicines in the U.S. are Sold In the latest video in PRI’s “Escape the Drug Pricing Maze” video, the Professor and Pete reach the most difficult part of their journey: understanding how medicines are sold. It’s a complex system that hurts patients and at times exposes ...
Blog

What We’re Watching – June 5

Tim Anaya – Digging Up Ways to Lower Costs for High Value but Expensive Drugs In the latest video in the “Escape the Drug Pricing Maze” video, Sage the Detective Dog digs up clues on biologics and gene therapies – drugs that offer tremendous value for patients but are some ...
Agriculture

What We’re Watching – May 22

Rowena Itchon – A Memorial Day Tribute 2020 Kerry Jackson – This Doctor Won’t Take Health Insurance – and Charges Just $35 a Visit Meet the Pittsburgh doctor who doesn’t take health care insurance and charges only $35 for most office visits. That makes him a doctor from a different era. But ...
Blog

What We’re Watching – May 8

Rowena Itchon – Love in the Time of Coronavirus Watch some of our front line medical personnel battling COVID-19 and helping people stay alive take a much-needed break to recreate the iconic scene from Titanic, with an usual, personal protective equipment-themed twist. Kerry Jackson – Dorothy’s Song, COVID-19 Version Somewhere, ...
Coronavirus

Sally Pipes – The Push for Government-Run Health Care During the Coronavirus Crisis

PRI President, CEO, and Thomas W. Smith Fellow in Health Care Studies Sally C. Pipes is back to discuss some of the health care challenges that have popped up during the coronavirus crisis, including a renewed push for single-payer and calls for prescription drug price controls and a “Buy America” ...
Blog

What We’re Watching – April 24

Tim Anaya – Taking a Time Machine to a Lower Drug Price Future In the latest video in the “Escape the Drug Pricing Maze” series, Professor Salvare takes Pete Paystoomuch in a time machine to learn how drugs become cheaper after higher initial costs that incentivize innovation. Then they go ...
Blog

COVID-19 Reminds Us That Both Innovation and Affordability Are Needed

In her March 25 Forbes editorial, Sally Pipes documented how the private sector is rising to the health challenges of the coronavirus. Whether it is Moderna launching clinical trials for a COVID-19 vaccine or Gilead Sciences investigating whether one of its medicines, Remdesivir, is effective against the coronavirus, private sector ...
Blog

What We’re Watching – Good Friday Edition

Tim Anaya – The Crossroads of Innovation and Affordability In the latest “Escape the Drug Pricing Maze” video, On the first step toward escaping the Drug Pricing Maze, Professor Salvare takes Pete Paystoomuch down the path of drug innovation, showing him why drug prices are initially more expensive – to ...
Scroll to Top